CNS outcomes in EGFR/ALK wild-type NSCLC patients with brain metastases treated with immune checkpoint inhibitors (ICI).

被引：0
|
作者：
Shultz, David Benjamin
Lau, Sally Cm
Poletes, Christopher
Le, Lisa W.
MacKay, Kate
Shepherd, Frances A.
Bradbury, Penelope Ann
Leighl, Natasha B.
Liu, Geoffrey
Sacher, Adrian G.
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Univ Hlth Network, Toronto, ON, Canada
[4] Princess Margaret Canc Ctr, Canc Clin Res Unit, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14505
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Clinical Outcomes of Non-Small Cell Lung Cancer Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitors, EGFR Tyrosine Kinase Inhibitors, Chemotherapy and Immune Checkpoint Inhibitors, or Chemotherapy Alone
    Dohm, A. E.
    Tang, J.
    Mills, M. N.
    Perez, B. A.
    Robinson, T. J.
    Creelan, B.
    Gray, J.
    Etame, A. B.
    Vogelbaum, M.
    Forsyth, P.
    Yu, H. H. M.
    Oliver, D. E.
    Ahmed, K. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E567 - E567
  • [22] Clinical outcomes of non-small cell lung cancer brain metastases treated with stereotactic radiosurgery and immune checkpoint inhibitors, EGFR tyrosine kinase inhibitors, chemotherapy and immune checkpoint inhibitors, or chemotherapy alone
    Dohm, Ammoren E.
    Tang, Joseph D.
    Mills, Matthew N.
    Liveringhouse, Casey L.
    Sandoval, Maria L.
    Perez, Bradford A.
    Robinson, Timothy J.
    Creelan, Benjamin C.
    Gray, Jhanelle E.
    Etame, Arnold B.
    Vogelbaum, Michael A.
    Forsyth, Peter
    Yu, Hsiang-Hsuan Michael
    Oliver, Daniel E.
    Ahmed, Kamran A.
    JOURNAL OF NEUROSURGERY, 2023, 138 (06) : 1600 - 1607
  • [23] Clinical Response to Apatinib Combined With Brain Radiotherapy in EGFR Wild-Type and ALK-Negative Lung Adenocarcinoma With Multiple Brain Metastases
    Ying, Xiaofang
    Liu, Huali
    Wang, Mingwei
    Peng, Min
    Ruan, Peng
    Verma, Vivek
    Han, Guang
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [24] Metabolic tumor burden as marker of outcome in advanced EGFR wild-type NSCLC patients treated with erlotinib
    Winther-Larsen, Anne
    Fledelius, Joan
    Sorensen, Boe Sandahl
    Meldgaard, Peter
    LUNG CANCER, 2016, 94 : 81 - 87
  • [25] Clinical efficacy of immune checkpoint inhibitors in patients with brain metastases
    Di Nunno, Vincenzo
    Nuvola, Giacomo
    Mosca, Mirta
    Maggio, Ilaria
    Gatto, Lidia
    Tosoni, Alicia
    Lodi, Raffaele
    Franceschi, Enrico
    Brandes, Alba Ariela
    IMMUNOTHERAPY, 2021, 13 (05) : 419 - 432
  • [26] Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors
    Serino, M.
    Freitas, C.
    Martins, M.
    Ferreira, P.
    Cardoso, C.
    Veiga, F.
    Santos, V.
    Araujo, D.
    Novais-Bastos, H.
    Magalhaes, A.
    Queiroga, H.
    Fernandes, G.
    Hespanhol, V.
    PULMONOLOGY, 2024, 30 (04): : 352 - 361
  • [27] Comparative Clinical Outcomes Between EGFR Exon20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors
    Bazhenova, L.
    Girard, N.
    Minchom, A.
    Ou, S.
    Gadgeel, S.
    Trigo, J. M.
    Viteri, S.
    Londhe, A.
    Mahadevia, P.
    Bauml, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S992 - S993
  • [28] Comparative Clinical Outcomes Between EGFR Ex20ins and Wildtype NSCLC Treated with Immune Checkpoint Inhibitors
    Girard, Nicolas
    Minchom, Anna
    Ou, Sai-Hong Ignatius
    Gadgeel, Shirish M.
    Trigo, Jose
    Viteri, Santiago
    Bauml, Joshua M.
    Londhe, Anil
    Mahadevia, Parthiv
    Bazhenova, Lyudmila
    CLINICAL LUNG CANCER, 2022, 23 (07) : 571 - 577
  • [29] Outcomes in Latin American NSCLC patients harboring wild-type or activating mutations of EGFR (CLICaP Registry).
    Cardona Zorrilla, Andres Felipe
    Arrieta, Oscar
    Federico Bramuglia, Guillermo
    Delia Campos-Parra, Alma
    Becerra Ramirez, Henry Alberto
    MARCELO Claudio, Martin
    Richardet, Eduardo
    Serrano, Silvia J.
    Archila, Pilar
    Rosell, Rafael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] Risk of CNS adverse events (CNS-AEs) for patients with non-small cell lung cancer (NSCLC) and melanoma brain metastases (BM) treated with CNS radiation (CNS-RT) and immune checkpoint inhibitors (CPIs)
    Devitt, Michael Edward
    Abraham, Ralph Sumner
    Hines, Jacobi
    Horton, Bethany J.
    Fadul, Camilo E.
    Larner, James Mitchell
    Sheehan, Jason
    Hall, Richard Delmar
    Gentzler, Ryan D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345